C11ORF30 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.944620E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.683800E-01
Normal-vs-Stage2
2.027200E-01
Normal-vs-Stage3
1.708190E-01
Normal-vs-Stage4
7.319000E-01
Stage1-vs-Stage2
5.241800E-01
Stage1-vs-Stage3
7.135800E-02
Stage1-vs-Stage4
8.610400E-01
Stage2-vs-Stage3
1.01459951551419E-10
Stage2-vs-Stage4
4.314400E-01
Stage3-vs-Stage4
1.633630E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.749810E-01
Normal-vs-AfricanAmerican
7.884000E-01
Normal-vs-Asian
1.629000E-01
Caucasian-vs-AfricanAmerican
1.589250E-01
Caucasian-vs-Asian
3.552400E-01
AfricanAmerican-vs-Asian
1.220600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.899950E-01
Normal-vs-Female
2.211200E-01
Male-vs-Female
7.342200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.622000E-01
Normal-vs-Age(41-60Yrs)
5.253400E-01
Normal-vs-Age(61-80Yrs)
1.165160E-01
Normal-vs-Age(81-100Yrs)
8.340000E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.328200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.151600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.613200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.782200E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.095580E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.805800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.311700E-02
Normal-vs-Daily Drinker
1.001620E-01
Normal-vs-Weekly Drinker
1.307790E-01
Normal-vs-Occasional Drinker
4.653800E-01
Normal-vs-Social Drinker
5.105400E-01
Non Drinker-vs-Daily Drinker
7.866400E-01
Non Drinker-vs-Weekly Drinker
9.023600E-01
Non Drinker-vs-Occasional Drinker
8.994500E-02
Non Drinker-vs-Social Drinker
9.768200E-02
Daily Drinker-vs-Weekly Drinker
9.204800E-01
Daily Drinker-vs-Occasional Drinker
1.010970E-01
Daily Drinker-vs-Social Drinker
1.119210E-01
Weekly Drinker-vs-Occasional Drinker
1.729000E-01
Weekly Drinker-vs-Social Drinker
1.835620E-01
Occasional Drinker-vs-Social Drinker
9.548800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.200960E-01
Normal-vs-Grade 2
3.521500E-02
Normal-vs-Grade 3
2.043500E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.088000E-01
Grade 1-vs-Grade 3
1.441380E-01
Grade 1-vs-Grade 4
1.200960E-01
Grade 2-vs-Grade 3
6.976600E-01
Grade 2-vs-Grade 4
3.521500E-02
Grade 3-vs-Grade 4
2.043500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.216440E-01
Normal-vs-NonDiabetic
1.335970E-01
Diabetic-vs-NonDiabetic
8.840400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.862640E-01
Normal-vs-NoPancreatitis
1.327040E-01
Pancreatitis-vs-NoPancreatitis
7.385600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.419800E-01
Normal-vs-N1
1.968580E-01
N0-vs-N1
8.712800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.946000E-01
Normal-vs-TP53-NonMutant
2.907600E-01
TP53-Mutant-vs-TP53-NonMutant
6.992200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
